SPHEREMAX
LIVE

Serial Number

79188909

Owner

NISSAN CHEMICAL INDUSTRIES, LTD.

Attorney

James A. Oliff

Filing Date

Jan 19, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SPHEREMAX Trademark

Serial Number: 79188909 • Registration: 5206829

SPHEREMAX is a trademark filed by NISSAN CHEMICAL INDUSTRIES, LTD. on January 19, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NISSAN CHEMICAL INDUSTRIES, LTD. (91 trademarks)

7-1, 3-CHOME, KANDA-NISHIKI-CHO
CHIYODA-KU, TOKYO , JP

Entity Type: 03

NISSAN CHEMICAL CORPORATION (108 trademarks)

CHUO-KU, TOKYO 103-6119 , JP

Entity Type: 03

Trademark Details

Filing Date

January 19, 2016

Registration Date

May 23, 2017

Published for Opposition

March 7, 2017

Cancellation Date

December 8, 2023

Goods & Services

Chemicals for use in industry and science, namely chemical media additives; chemical preparations for use in industry, namely chemical media additives; chemical preparations for scientific purposes, namely chemical media additives; chemical media additives, other than for medical or veterinary purposes; chemical media additives in kit form, other than for medical or veterinary purposes; chemical media additives for scientific or research purposes, other than for medical or veterinary purposes; chemical media additives in kit form for scientific or research purposes, other than for medical or veterinary purposes; chemical media additives for cell culture, other than for medical or veterinary purposes; chemical media additives for tissue culture, other than for medical or veterinary purposes; chemical media additives for culture of microorganisms, other than for medical or veterinary purposes; media for cell culture for scientific or research purposes, other than for medical or veterinary purposes; media for tissue culture for scientific or research purposes, other than for medical or veterinary purposes; media for culture of microorganisms for scientific or research purposes, other than for medical or veterinary purposes; media for three-dimensional cell culture for scientific or research purposes, other than for medical or veterinary purposes; media for three-dimensional tissue culture for scientific or research purposes, other than for medical or veterinary purposes; media for three-dimensional culture of microorganisms for scientific or research purposes, other than for medical or veterinary purposes; media for cell culturing for laboratory use; dispersing agents; chemical media additives for use in separation of cells, other than for medical or veterinary purposes; media for cell culture in kit form for scientific or research purposes, other than for medical or veterinary purposes; media for tissue culture in kit form for scientific or research purposes, other than for medical or veterinary purposes; media for culture of microorganisms in kit form for scientific or research purposes, other than for medical or veterinary purposes; all of the above not including reagents and diagnostic materials

Pharmaceutical preparations for use in regenerative medicine, oncology and hematology; pharmaceutical preparations for the treatment of viral and infectious diseases, autoimmune diseases, kidney diseases, hepatic diseases, neurological diseases and bone diseases; chemical media additives for medical or veterinary purposes; chemical media additives in kit form for medical or veterinary purposes; chemical media additives for cell culture, for medical or veterinary purposes; chemical media additives for tissue culture, for medical or veterinary purposes; chemical media additives for culture of microorganisms, for medical or veterinary purposes; culture media for use in regenerative medicine, oncology, hepatology and hematology; culture media for augmentation of bone and other tissues for medical purpose using iPS/ES cells and other stem cells; culture media for use to produce biomedicine, in particular antibody medicines and vaccine medicines; culture media of microorganisms for medical use; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; all of the above not including reagents and diagnostic materials

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 12, 2024 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Sep 8, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 20, 2024 INTS
INVALIDATION PROCESSED
Aug 20, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 9, 2024 INTR
CANCELLED SECTION 71
Dec 8, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 23, 2022 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 13, 2018 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 20, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 25, 2017 FICS
FINAL DISPOSITION PROCESSED
Aug 25, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 23, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
May 23, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 7, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 7, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Mar 3, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 15, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 15, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 1, 2017 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 19, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 19, 2017 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2017 TROA
REFUSAL PROCESSED BY IB
Aug 5, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 19, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jul 19, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 19, 2016 RFCR
APPLICATION FILING RECEIPT MAILED
Jul 19, 2016 MAFR
NON-FINAL ACTION WRITTEN
Jul 17, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 14, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2016 REPR